BENSALEM, Pa., Jan. 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MARCH 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices o ...

Core Viewpoint - Elevance Health, Inc. (ELV) is expected to report its fourth-quarter 2025 results on January 28, 2026, with earnings estimated at $3.10 per share and revenues of $49.59 billion [1] Financial Performance - The fourth-quarter earnings estimate has seen one downward revision and no upward revisions in the past month, indicating a year-over-year decline of 19.3% in earnings, while revenues are projected to increase by 10.2% year-over-year [2] - For the full year 2025, the Zacks Consensus Estimate for Elevance's revenues is $197.98 billion, reflecting a 13% year-over-year increase, while the EPS estimate is $29.99, showing a 9.2% year-over-year decrease [3] Earnings Prediction - The current Earnings ESP for Elevance is -1.41%, and it holds a Zacks Rank of 4 (Sell), suggesting that an earnings beat is unlikely this quarter [4] Revenue Drivers - The consensus estimate for product revenues indicates a 1.5% growth from the previous year's $6.7 billion, while premiums are expected to rise by 12.3% year-over-year, contributing to overall sales growth [5] - The estimate for Commercial Individual membership suggests a 3.5% growth year-over-year, although Commercial Fee-based memberships are projected to decline by 0.4% [6] Operating Income - The Zacks Consensus Estimate for Carelon brand's operating income indicates an 8.9% year-over-year increase, driven primarily by growth in CarelonRx, while the Health Benefits segment's operating income is expected to rise by 12.1% [7] Expense Outlook - Elevated expenses are anticipated due to significant investments in digital capabilities, with total expenses expected to increase by 8.4% year-over-year in the fourth quarter [8]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Ardent Health, Inc. related to misrepresentation and failure to disclose critical financial information [1][2]. Group 1: Allegations of Misrepresentation - Insiders at Ardent Health allegedly misrepresented the company's reliance on "detailed reviews of historical collections" for determining the collectability of accounts receivable [2]. - The accounts receivable framework reportedly utilized a "180-day cliff," allowing Ardent Health to report inflated accounts receivable and postpone recognizing losses on uncollectible accounts [2]. - It was disclosed that Ardent Health did not maintain sufficient professional malpractice liability insurance to cover claims arising from its operations [2]. Group 2: Shareholder Involvement - Shareholders who purchased ARDT prior to July 18, 2024, are encouraged to contact Kuehn Law to enforce their rights, as there may be limited time to act [2]. - The firm emphasizes the importance of shareholder participation in maintaining the integrity and fairness of financial markets [3].

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183202&from=4 CLASS PERIOD: July 18, 202 ...

Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) has experienced significant stock price declines, prompting discussions about its investment potential [1][2] - Jim Cramer suggests that UnitedHealth is currently undervalued and recommends buying it, highlighting the effectiveness of its CEO and the company's resilience in overcoming past challenges [2] - Despite the positive outlook for UnitedHealth, there are opinions that certain AI stocks may present better investment opportunities with higher upside potential and lower downside risk [3] Group 2 - The company provides a range of services including health care, insurance plans, pharmacy care, and data-driven solutions, indicating its diversified business model [2] - Cramer emphasizes the importance of the leadership at UnitedHealth, suggesting that the CEO should be featured on his show to discuss the company's direction [2]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - January 21, 2026) ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Ardent Health, Inc. regarding a class action lawsuit due to alleged false statements and misleading financial practices related to accounts receivable and professional liability reserves [1][3]. Group 1: Allegations - The complaint alleges that Ardent Health did not rely on "detailed reviews of historical collections" for determining the collectability of accounts receivable, instead using a 180-day cliff for reserving accounts, which inflated reported receivables [3]. - It is claimed that Ardent Health's professional liability reserves were insufficient to cover claims due to "significant social inflationary pressure" in medical malpractice cases, particularly in the New Mexico market [3]. Group 2: Class Action Details - The class period for the lawsuit is from July 18, 2024, to November 12, 2025, and shareholders are encouraged to register for participation by March 9, 2026 [4]. - Shareholders who register will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud, aiming to ensure responsible business practices [5].

Corporate Rebranding - KindlyMD, Inc. has changed its corporate name to Nakamoto Inc. to align its identity with its long-term strategy in the Bitcoin ecosystem [1] Industry Trends - In 2025, many companies transitioned to digital assets, following the model established by MicroStrategy, which began accumulating Bitcoin during the COVID-19 pandemic [2] - The trend of companies building digital asset treasuries (DATs) was popularized by MicroStrategy, leading others, including KindlyMD, to follow suit [3] Mergers and Acquisitions - KindlyMD merged with Nakamoto Holdings, marking a significant crossover between traditional enterprises and the digital asset ecosystem [4] Market Dynamics - Bitcoin experienced significant price fluctuations, particularly after political events, such as Donald Trump's return to the White House and subsequent tariff threats, which caused a flash crash [5][6] - The volatility of Bitcoin has led to concerns about delisting from stock indices, as seen with MicroStrategy facing threats from MSCI due to its Bitcoin holdings [6][7]

Core Insights - Amazon has launched an AI assistant for its One Medical app to enhance healthcare experiences by providing personalized health guidance and facilitating communication with care teams [2][3] Group 1: AI Assistant Features - The AI tool assists users with health questions, appointment scheduling, and medication management [2] - It offers 24/7 personalized health guidance based on individual medical histories and connects patients to their care teams when clinical expertise is needed [3] Group 2: Industry Context - The integration of AI in healthcare is growing, with nearly half of healthcare organizations using generative AI for documentation and administrative tasks [4] - A survey by the American Medical Association found that over half of doctors believe AI can enhance clinical functions, with 72% stating it could improve diagnostic abilities [5] Group 3: Benefits and Risks of AI in Healthcare - AI can alleviate the burden on healthcare systems by addressing basic inquiries and simplifying complex administrative issues, thus reducing friction for patients and providers [6] - However, the risks associated with generative AI include the potential for producing incomplete or incorrect responses, which can have serious implications in healthcare [7]

Core Insights - Private health insurance penetration rates in the US increase significantly with household income, indicating affordability as a major barrier for lower-income groups [2] - President Trump's healthcare legislative proposal aims to reduce costs for consumers and improve access to coverage, focusing on lowering prescription drug prices and insurance premiums [3][4] Group 1: Private Health Insurance Penetration - The GlobalData survey reveals that only 19.4% of respondents earning $0–$19,999 have private health insurance, compared to 50.9% of those earning $150,000 or more [2] - This disparity highlights the affordability issue that affects lower-income households and their access to private health insurance [2] Group 2: Legislative Proposal Overview - The 'Great Healthcare Plan' proposed by President Trump seeks to align US prescription drug prices with international benchmarks and enhance price transparency in the healthcare system [3] - A key feature of the proposal is the overhaul of federal subsidies, directing funds to eligible individuals instead of insurers, which is expected to increase competition and lower average premiums by over 10% [4] Group 3: Cost Reduction Measures - The proposal aims to eliminate certain payments involving pharmacy benefit managers and brokers, which are seen as inflating coverage prices [5] - New disclosure requirements would mandate insurers to publish policy prices, benefits, claims denial rates, and administrative costs in clear language, extending similar obligations to Medicare and Medicaid providers [5] Group 4: Potential Impact on the Market - If implemented, these measures could enhance affordability and accessibility for lower-income households, potentially narrowing the income-related coverage gap and increasing private health insurance penetration rates [6] - The reforms are expected to foster price competition and transparency among insurers, leading to changes in product design and pricing strategies as the market adapts to greater consumer choice and cost sensitivity [6]